"If taking medications that decrease appetite or insulin requirements, people with type 1 diabetes still must continue taking their long-acting insulin or using their insulin pump." Semaglutide, vomiting, and DKA: A case study In a 2023 case report, a person with type 1 arrived at an emergency room with ketoacidosis, after suffering nausea and vomiting attributed to taking Wegovy (semaglutide) prescribed by his endocrinologist for weight loss
This three-entity structureplatform, providers, pharmacyensures appropriate separation between technology coordination, clinical decision-making, and medication dispensing
Publication bias by abandonment
Researchers then randomized 670 participants to take either tirzepatide or placebo for another 52 weeks (double blinded)
Pros of using compounded semaglutide Compounded semaglutide has grown in popularity for good reason
Poor sleep, which commonly accompanies anxiety, further disrupts the hormones that regulate hunger and cravings